Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Dixon

Showing results (11-20 of 230) with videos related to

Pageof 23
Sort By:
BMJ (Clinical Research Ed.)|March 6, 2002
One stop clinics should not be abandonedJ Michael Dixon
Expert Opinion on Pharmacotherapy|December 8, 2006
Aromatase inhibitors in early breast cancer therapy: a variety of treatment strategiesJ Michael Dixon
BMJ (Clinical Research Ed.)|March 4, 2006
Screening for breast cancerJ Michael Dixon
Breast (Edinburgh, Scotland)|May 21, 2008
Reducing early recurrence with adjuvant aromatase inhibitors: what is the evidence?J Michael Dixon
BMJ (Clinical Research Ed.)|November 2, 2002
Message about hormone replacement therapy is unclearJ Michael Dixon
Breast Cancer Research and Treatment|December 15, 2004
The scientific value of preoperative studies and how they can be usedJ Michael Dixon
Annals of Surgical Oncology|July 23, 2016
Sentinel Lymph Node Biopsy in Breast Cancer SurgeryJ Michael Dixon
Expert Review of Anticancer Therapy|March 28, 2008
Prospects of neoadjuvant aromatase inhibitor therapy in breast cancerJ Michael Dixon
Breast Cancer Research : BCR|December 25, 2009
Breast screening has increased the number of mastectomiesJ Michael Dixon
Expert Review of Anticancer Therapy|July 13, 2002
Exemestane: a potent irreversible aromatase inactivator and a promising advance in breast cancer treatmentJ Michael Dixon
Pageof 23

Showing results (11-20 of 230) with videos related to

Sort By:
Pageof 23
BMJ (Clinical Research Ed.)|March 6, 2002
One stop clinics should not be abandonedJ Michael Dixon
Expert Opinion on Pharmacotherapy|December 8, 2006
Aromatase inhibitors in early breast cancer therapy: a variety of treatment strategiesJ Michael Dixon
BMJ (Clinical Research Ed.)|March 4, 2006
Screening for breast cancerJ Michael Dixon
Breast (Edinburgh, Scotland)|May 21, 2008
Reducing early recurrence with adjuvant aromatase inhibitors: what is the evidence?J Michael Dixon
BMJ (Clinical Research Ed.)|November 2, 2002
Message about hormone replacement therapy is unclearJ Michael Dixon
Breast Cancer Research and Treatment|December 15, 2004
The scientific value of preoperative studies and how they can be usedJ Michael Dixon
Annals of Surgical Oncology|July 23, 2016
Sentinel Lymph Node Biopsy in Breast Cancer SurgeryJ Michael Dixon
Expert Review of Anticancer Therapy|March 28, 2008
Prospects of neoadjuvant aromatase inhibitor therapy in breast cancerJ Michael Dixon
Breast Cancer Research : BCR|December 25, 2009
Breast screening has increased the number of mastectomiesJ Michael Dixon
Expert Review of Anticancer Therapy|July 13, 2002
Exemestane: a potent irreversible aromatase inactivator and a promising advance in breast cancer treatmentJ Michael Dixon
Pageof 23